Our Backers

Molecular Future
6 min readDec 9, 2017

--

As with any other industry, the ability for a project to launch successfully often depends on its ability to access cash, either from its own accounts or those willing to provide funding. No matter the determination of the founders or its fledgling community, cold, hard cash is a pre-requisite. Facebook received $500,000 from Peter Thiel (and later $12.7 million from Thiel and Accel partners), Apple almost went bankrupt until it hired Steve Jobs back and made a $150 million deal with Microsoft, and over 29% of other startups will go bankrupt due to lack of funding.

Funding and access to money is overwhelmingly important to the process of creating a business. For a company like Poloniex, a digital asset exchange platform, it will realistically need millions or even tens of millions of dollars before it can go live. The founders will need to employ web designers, cyber security experts, foreign exchange specialists, blockchain and fintech lawyers, and many more unique people, and even after that, the company would still need to store large liquidity reserves.

This is a good example of the need for funding, but funding alone won’t magically solve all problems a project may have. This is where experience and strategic leadership are so vitally critical to any company looking to make its mark, and exist in the long term. According to entrepreneur.com 75% of all venture-backed startups will fail, and a leading reason behind that is a lack of good mentorship.

In light of these important facts, Molecular Future is proud to say that it has managed to receive funding and support from five large financial investment companies, and one blockchain technology company, each of who have agreed to continually back Molecular Future through its development.

In this article, we’ve provided a brief overview of each of these companies to instill a sense of confidence and direction in our future users.

The Eagles Fund is a diversified venture capital fund with a focus on internet innovation and advanced technology. The fund is divided into nine sections, six of which are denominated in the Chinese RMB, and three are in American USD. Currently, the fund has over 600 million RMB and 30 million USD under management. The Eagles Fund has offices in Beijing and Shanghai servicing its nearly 200 startup projects, covering artificial intelligence, financial technology, the sharing economy, medical health, etc. Under the direction of the well-known, legendary angel investor Liu Xiaoying, many of the invested startups are running a profit, and many have been publicly listed on the Hong Kong stock exchange. In addition, the fund has also received numerous awards from China’s Mother Fund Alliance, ChinaVenture, CYZone, and other institutions for its successes as an outstanding investment institution.

HBCC is a Hong Kong based investment company established by a group of seasoned venture capitalists with years of experience and a proven track record in cross boarder business development. The firm has a focus on early-stage value investment in science and technology companies. Previously, the company has invested in healthcare, big data, artificial intelligence, the internet of things, new energy and FinTech. In addition to their experienced team, HBCC is partnered with some of China’s top ten angel investors including: Mr. Liu Xiaoying (Eagles Fund founder), Mr. Li Hansheng (Shanggu Capital founder), Mr. He Shaojun (Cloud Brain Fund partner), Ms. Wu Man (TenplusVC), and Ms. Zhang Huisi (TUS International executive director). HBCC’s fund management partners’ manage assets in excess of 500 million RMB.

The Molecular Group is an innovative financial investment company based in Hong Kong with operations spanning: asset management, lease financing, venture capital, internet finance, blockchain projects, financial consulting, and energy. Using the principles of internet finance, the Molecular Group has expanded highly transparent, big-data based investments — a feat not possible with traditional financial methods, which allows an optimised spread of funds across different projects, fundamentally creating strong and steady gains for investors. The group has invested tens of millions of dollars in the Blockchain industry, and continues to expand its investments in the sector. The group is led by infamous early bitcoin investor and risk management expert, Jason Tso.

Collinstar Capital is an Australian asset management company with a venture capital arm, specializing in FinTech, blockchain and cryptocurrency investments. Established in 2015, the firm has become one of the world’s leading blockchain and cryptocurrency investment firms. The company prides itself on being early investors in many emerging cryptocurrencies, including Bitcoin, Ethereum and Litecoin. Since 2016, the firm has provided venture capital financing, advisory, research and general support to dozens of early blockchain projects, a majority of which launched with great success. Under the guidance of Ryan Xu, a legendary blockchain investor and previous nuclear engineer from the Shanghai Jiao Tong University, and his experienced investment team, the company aims to continually develop and fund innovative and disruptive projects. An example of a successfully launched project that was supported by Collinstar is Hcash. Hcash is a decentralized and open-source cross platform cryptocurrency that integrates both blockless and block-based DAG systems. Collinstar was selected to be its lead project manager, and with its direction and support, the currency (known as Hshares: HSR) stands as the 22nd largest cryptocurrency by market capitalization (>USD $790m).

The Hcash Foundation is an organisation with the purpose of promoting the education, adoption, and growth of the Hcash ecosystem. It seeks to aid individuals, schools, universities, small businesses, corporations, NPOs, charities, councils, and state and federal governments understand blockchain technology, the innovations Hcash provides, and information concerning how to connect these organisations to the blockchain. Hcash will be providing its blockchain technology solution to Molecular Future. With seasoned experts and a full development team, Hcash will ensure that Molecular Future will be provided with a state of the art, innovative and efficient public ledger system.

The XBTING foundation is a financial establishment with the focus on the investment and incubation of blockchain projects, as well as conducting arbitrage and hedging of digital assets. Since its inception in 2016, the foundation has return over 50% annually to its investors, and in 2017 alone the firm has achieved a return of over 290%. With a net worth of over 30 million RMB and an annual profit of over 10 million RMB, its strategies lie in using its unique big data analytics, risk-control systems and a diverse project investment portfolio that takes advantage of market inefficiencies and project opportunities. XBTING prides itself on being one of the earliest investment foundations that has entered the digital asset industry.

Overall, combining these six organizations above provides a core advantage to Molecular that other projects lack. The financial investment companies will provide financing, mentorship and connections to startup companies across differing promising industries, while the Hcash foundation will provide a complete and refined blockchain solution. This will give Molecular its best possible chance of success, and means that the aforementioned downfalls apparent in other failed startups, particularly lack of funding and guidance will be avoided.

--

--